# An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis

> **NCT01037179** · PHASE3 · COMPLETED · sponsor: **Alcon Research** · enrollment: 110 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** Olopatadine Hydrochloride Ophthalmic Solution, 0.2%

## Key facts

- **NCT ID:** NCT01037179
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2014-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01037179

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01037179, "An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic Conjunctivitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01037179. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*